- Latest available (Revised)
- Original (As adopted by EU)
Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
Component | Quality measurements required The required frequency of sampling for all measurements shall be determined using statistical process control | Acceptable results for quality measurements |
---|---|---|
Red cells | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 45 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, buffy coat removed | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 43 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40 g per unit | |
Leucocyte content | Less than 1 × 106 per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 45 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, buffy coat removed, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 43 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, leucocyte-depleted, in additive solution | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40 g per unit | |
Leucocyte content | Less than 1 × 106 per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Red cells, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis |
Haemoglobin (*) | Not less than 40 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Whole blood | Volume | Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis 450 ml +/- 50ml For paediatric autologous whole blood collections — not to exceed 10,5 ml per kg body weight |
Haemoglobin (*) | Not less than 45 g per unit | |
Haemolysis | Less than 0,8 % of red cell mass at the end of the shelf life | |
Platelets, apheresis | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Platelets, apheresis, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 1 × 106 per unit | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Platelets, recovered, pooled | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 0,2 × 109 per single unit (platelet-rich plasma method) Less than 0,05 × 109 per single unit (buffy coat method) | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Platelets, recovered, pooled, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 1 × 106 per pool | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Platelets, recovered, single unit | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions | |
Leucocyte content | Less than 0,2 × 109 per single unit (platelet-rich plasma method) Less than 0,05 × 109 per single unit (buffy coat method) | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Platelets, recovered, single unit, leucocyte-depleted | Volume | Valid for storage characteristics to maintain product within specifications for pH |
Platelet content | Variations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions | |
Leukocyte content | Less than 1 × 106 per unit | |
pH | [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life] | |
Plasma, fresh-frozen | Volume | Stated volume +/- 10 % |
Factor VIIIc (*) | Average (after freezing and thawing): 70 % or more of the value of the freshly collected plasma unit | |
Total protein (*) | Not less than 50 g/l | |
Residual cellular content (*) | Red cells: less than 6,0 × 109/l Leucocytes: less than 0, 1 × 109/l Platelets: less than 50 × 109/l | |
Plasma, fresh-frozen, cryoprecipitate-depleted | Volume | Stated volume: +/- 10 % |
Residual cellular content (*) | Red cells: less than 6,0 × 109/l Leucocytes: less than 0,1 × 109/l Platelets: less than 50 × 109/l | |
Cryoprecipitate | Fibrinogen content (*) | Greater than or equal to 140 mg per unit |
Factor VIIIc content (*) | Greater than or equal to 70 international units per unit | |
Granulocytes, apheresis | Volume | Less than 500 ml |
Granulocyte content | Greater than 1 × 1010 granulocytes per unit |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: